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On the basis of pharmacological, behavioral and bio-
chemical studies, opioid receptors have been classified
into three major types, μ, δ and κ, belonging to the family
of the G protein-coupled receptors. All three receptor
types are expressed in the central and peripheral nervous
systems of both animals and human. Receptor type selec-
tive opioid agonists and antagonists are of interest both as
pharmacological tools and as potential therapeutic agents
for the treatment of pain, addiction, constipation or
immunological diseases. During the past 3 decades, one
of the major aims of medicinal chemistry and opioid
pharmacology has been to develop opioids with high
affinity and/or selectivity for each of the three receptor
types. In this study, 14-alkoxy analogues of naltrindole,
naloxindole and naltriben with different benzyloxy sub-
stitution in position 14 have been investigated to elabo-
rate on structure-activity relationships (SAR) of the
morphinan class of compounds. To this aim, several 14-
benzyloxy substituted indolo- and benzofuromorphinans
were prepared by multi-step synthesis using naloxone and
naltrexone as starting materials. Binding affinities and
selectivities to opioid receptors (μ, δ and κ) were deter-
mined using in vitro binding assays with rodent brain
membranes employing selective opioid radioligands.
Examination of the chemical structure and opioid binding
profile i.e. affinities and selectivities reveals certain SAR
for the investigated compounds. Opioid binding affinity
was sensitive to the character and length of the substituent
in position 14. Introduction of 14-benzyloxy groups
resulted in reduced affinity and selectivity for the δ recep-
tor. The replacement of the N-allyl by an N-cyclopropyl-
methyl group in position 17 resulted in increased δ
affinity without affecting δ receptor selectivity. The results
of the present study indicate that position 14 of indolo-
and benzofuromorphinans represents a critical site that
could be a trigger to develop opioid compounds with
increased δ affinity and/or selectivity. These findings pro-
vide further evidence that the nature of the substituent at
position 14 has a major impact on the abilities of morphi-
nans to interact with opioid receptors.
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